logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research- North Hollywood, California

Verified
+18184873741
Source: Site record.
https://velocityclinicaltrials.com/locations/velocity-clinical-research-north-hollywood

Basic Information

Site Overview

Source: Google.

Velocity’s North Hollywood research site was founded in 2004 as Providence Clinical Research by Dr. Teresa Sligh and Dr. Scott Sligh, and acquired by Velocity in 2019. The research center focuses on clinical trials for numerous indications, including Type II Diabetes, Anemia, Asthma/COPD, Arthritis of knee and hip, Cardiovascular disease, Chronic low back pain, Constipation, Genital herpes, Gout, Chronic Kidney Disease, Hepatitis B and C, Influenza, Irritable bowel syndrome, Kidney disease, Hypogonadism, Chronic Pain, dermatological disorders, Smoking, and Tinnitus.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
36Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
4Active Trials
Source: Trial-derived.
29Completed Trials
Source: Trial-derived.
36Unique Conditions
Source: Trial-derived.
30Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Atopic Dermatitis (6)Source: Trial-derived. Diabetes Mellitus, Type 2 (3)Source: Trial-derived. Osteoarthritis, Knee (3)Source: Trial-derived. Influenza Immunization (2)Source: Trial-derived. Psoriasis (2)Source: Trial-derived. Acute Treatment of Migraine (1)Source: Trial-derived. Cardiovascular Diseases (1)Source: Trial-derived. Chronic Pain (1)

Sponsors

Source: Trial-derived. Pfizer (4)Source: Trial-derived. AbbVie (3)Source: Trial-derived. Allergan Sales, LLC (3)Source: Trial-derived. Novo Nordisk A/S (3)Source: Trial-derived. Sanofi Pasteur, a Sanofi Company (3)Source: Trial-derived. Amgen (2)Source: Trial-derived. Ironwood Pharmaceuticals, Inc. (2)Source: Trial-derived. ModernaTX, Inc. (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. 12-lead ECG
Source: AI-inferred. Continuous glucose monitoring
Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Actigraphy (accelerometer) activity monitoring
Source: AI-inferred. App-based insulin dose guidance
Source: AI-inferred. Blood glucose meter monitoring
Source: AI-inferred. Electronic participant diary (eDiary/ePRO)
Source: AI-inferred. Electronic participant diary platform
Source: AI-inferred. Electronic patient-reported outcome diary (ePRO)